 Although it is not clear whether people with Dravet syndrome are specially vulnerable to COVID-19 infection, recent publications have shown that affected individuals and their families have suffered some indirect damages during COVID-19 pandemic, such as healthcare barriers, loss of therapies or economic issues.Charlotte Dravet first described severe myoclonic epilepsy of infancy in Centre Saint Paul, Marseille France in 1978 and the name was later changed to Dravet syndrome in 1989.Similar descriptions were given by Bernardo Dalla Bernardina in Verona.